feed,title,long_url,short_url
Benzinga,Revolution Medicines' Early-Data Validation For Cancer Program Wins Price Target Boost By This Analyst,https://benzinga.com/general/biotech/23/02/31098776/revolution-medicines-early-data-validation-for-cancer-program-wins-price-target-boost-by-this-ana,https://da.gd/47zikY
